Camilla Genovese
Overview
Explore the profile of Camilla Genovese including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
17
Citations
34
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Colaneri M, Galli L, Offer M, Borgonovo F, Scaglione G, Genovese C, et al.
Antibiotics (Basel)
. 2025 Jan;
14(1).
PMID: 39858313
: Vascular access device (VAD)-associated infections, including catheter-related (CRBSI) and catheter-associated bloodstream infections (CABSI), present significant challenges in patient care. While multidisciplinary VAD teams (VATs) are equipped with protocols for...
2.
Genovese C, Mahida B, Rouzet F, Timsit J, Thy M
Intensive Care Med
. 2025 Jan;
51(2):418-420.
PMID: 39774868
No abstract available.
3.
Comelli A, Genovese C, Renisi G, Scudeller L, Zanforlini M, Macaluso G, et al.
Infect Prev Pract
. 2024 Dec;
6(4):100416.
PMID: 39691840
A Delphi consensus-seeking procedure was conducted to validate a list of ICD-9-CM codes that could help identify hospital admissions in which antimicrobials are more likely to be prescribed. The panel...
4.
Canuti M, Fassio F, Genovese C, Giacomelli A, Ridolfo A, Asperges E, et al.
Infect Dis Ther
. 2024 Oct;
13(11):2471-2474.
PMID: 39352650
No abstract available.
5.
Scaglione G, Colaneri M, Offer M, Galli L, Borgonovo F, Genovese C, et al.
Microorganisms
. 2024 Aug;
12(8).
PMID: 39203438
Introduction: Vascular access devices (VADs), namely peripheral VADs (PVADs) and central venous VADs (CVADs), are crucial in both intensive care unit (ICU) and non-ICU settings. However, VAD placement carries risks,...
6.
Scaglione G, Perego M, Colaneri M, Genovese C, Brivio F, Covizzi A, et al.
Front Microbiol
. 2024 Jun;
15:1405390.
PMID: 38903794
Introduction: In patients admitted to intensive care units (ICUs), Gram-negative bacteria (GNB) infections pose significant challenges due to their contribution to morbidity, mortality, and healthcare costs. During the SARS-CoV-2 pandemic,...
7.
Colaneri M, Genovese C, Fassio F, Canuti M, Giacomelli A, Ridolfo A, et al.
Infect Dis Ther
. 2024 Apr;
13(5):1147-1157.
PMID: 38643431
Introduction: Recent studies have highlighted the prognostic value of easily accessible inflammatory markers, neutrophil-to-lymphocyte ratio (NLR), and platelet-to-lymphocyte ratio (PLR) for predicting severe outcomes in patients affected by Coronavirus disease...
8.
Colaneri M, Genovese C, Lombardi A, Holmes D, Bandera A, Gori A
Eur J Clin Microbiol Infect Dis
. 2024 Mar;
43(5):1017-1023.
PMID: 38457097
While a tailored antibiotic treatment plan is often straightforward, what we often observe in daily clinical practice is a highly variable approach when defining empirical therapy. Specifically, a debate exists...
9.
Cattaneo D, Fusi M, Galli L, Genovese C, Giorgi R, Matone M, et al.
Antimicrob Agents Chemother
. 2024 Feb;
68(4):e0002324.
PMID: 38385700
Here, we describe the use of proactive therapeutic drug monitoring (TDM) to individualize the optimal timing of drug injections in 16 adult patients with chronic osteoarticular infections receiving a median...
10.
Colaneri M, Genovese C, Valsecchi P, Calia M, Cattaneo D, Gori A, et al.
Eur J Drug Metab Pharmacokinet
. 2024 Feb;
49(2):123-129.
PMID: 38332425
Intravenous drug users (IVDUs) face heightened susceptibility to life-threatening gram-positive bacterial infections, particularly methicillin-resistant Staphylococcus aureus (MRSA). While the standard antibiotic dosing strategies for special patients, such as obese or...